Literature DB >> 6748384

Muscarinic cholinergic receptors in human gastric mucosa.

T Tokunaga, R Nishimura, M Akagi.   

Abstract

Muscarinic cholinergic receptor sites in human gastric mucosa were analyzed directly by using radioligand binding techniques with the specific muscarinic antagonist 3H-quinuclidinyl benzilate (QNB) as ligand. Specific binding of 3H-QNB to membrane preparations from human gastric mucosa was saturable, of high affinity (Kd = 4.17 +/- 1.94 nM, Bmax = 0.37 +/- 0.04 pmol/mg protein) and selectively inhibited by muscarinic antagonists (atropine, scopolamine) and agonists (acetylcholine, pilocarpine). These findings provide direct evidence for the existence of muscarinic cholinergic receptors in human gastric mucosa. The specific 3H-QNB binding to its receptor was blocked by atropine but not by histamine, cimetidine, pentagastrin, or synthetic human gastrin. The muscarine and histamine H2-receptor, or muscarine and gastrin receptor, probably do not share the same locus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6748384     DOI: 10.1007/BF02469802

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  19 in total

Review 1.  Regulation of gastric acid secretion.

Authors:  H T Debas
Journal:  Fed Proc       Date:  1977-06

Review 2.  Peptide hormone receptors.

Authors:  K J Catt; M L Dufau
Journal:  Annu Rev Physiol       Date:  1977       Impact factor: 19.318

3.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

4.  The binding of antagonists to brain muscarinic receptors.

Authors:  E C Hulme; N J Birdsall; A S Burgen; P Mehta
Journal:  Mol Pharmacol       Date:  1978-09       Impact factor: 4.436

5.  Cardiac muscarinic cholinergic receptors. Biochemical identification and characterization.

Authors:  J Z Fields; W R Roeske; E Morkin; H I Yamamura
Journal:  J Biol Chem       Date:  1978-05-10       Impact factor: 5.157

6.  Inhibition of acid secretion in dog by metiamide, a histamine antagonist acting on H2 receptors.

Authors:  M I Grossman; S J Konturek
Journal:  Gastroenterology       Date:  1974-04       Impact factor: 22.682

7.  Kinetics of atropine inhibition of pentagastrin-stimulated H+, electrolyte, and pepsin secretion in the dog.

Authors:  B I Hirschowitz; G A Hutchison
Journal:  Am J Dig Dis       Date:  1977-02

8.  The actions of secretagogues on oxygen uptake by isolated mammalian parietal cells.

Authors:  A H Soll
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

9.  Muscarinic cholinergic binding in rat brain.

Authors:  H I Yamamura; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

10.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

View more
  2 in total

1.  Intragastric injection of botulinum toxin A for the treatment of obesity.

Authors:  Reinhard Mittermair; Christian Keller; John Geibel
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

2.  Botulinum toxin in gastric submucosa reduces stimulated HCl production in rats.

Authors:  Matteo Runfola; Simone Rossi; Simona Panunzi; Pier Luigi Spada; Daniele Gui
Journal:  BMC Gastroenterol       Date:  2003-09-10       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.